Peter Kolchinsky
Independent DirectorDr. Peter Kolchinsky, Ph.D., is Director of Slate Medicines, Inc. Dr. Kolchinsky is Director of Freenome, Inc since December 2020. He has Ph.D. in Virology from Harvard University. He has B.A. in Biology from Cornell University. He joined the RA Capital Management, L.P. in 2004. He was Portfolio Manager & MD of RA Capital Management, L.P. He was Co-Founder, Managing Partner & Partner of RA Capital Management, L.P. He was Managing General Partner, General Partner & Founding Member/Managing Member of RA Capital Management, L.P. He is Independent Director of Wave Life Sciences, Inc. from January 2015. He joined the Wave Life Sciences, Inc. in January 2015. He is Member of Advisory Board of Activate Networks, Inc. He is Director of Lantos Technologies, Inc. He is Director of Vaxess Technologies, Inc. He was Director of Vaxess Technologies, Inc. He is Director of PiloFocus, Inc. He is Director of Sojournix, Inc. from 2016. He is Board Member of Forma Therapeutics, Inc. from December 2019. He is Director of Adeo Health Science, Inc. He is Independent Director of ARS Pharmaceuticals, Inc. from August 2021. He is Independent Director of Icosavax, Inc. from March 19, 2021. He joined the Icosavax, Inc. in March 2021. He is Director of Nature's Toolbox, Inc. He is Co-Founder, Chairman & CEO of Research Alliance Corp. II. He was Independent Director of Dicerna Pharmaceuticals, Inc. from July 2013 to December 13, 2019. He was employed at Dicerna Pharmaceuticals, Inc. from July 2013 to December 13, 2019. He was Director of Synthorx, Inc. from May 2018 to January 22, 2020. He was employed at Synthorx, Inc. from May 2018 to January 22, 2020. He was Director of G1 Therapeutics, Inc. He was employed at G1 Therapeutics, Inc. from February 05, 2015 to May 22, 2017. He was Independent Non-Executive Director of Forma Therapeutics Holdings, Inc. from December 2019 to October 14, 2022. He was employed at Forma Therapeutics Holdings, Inc. until October 14, 2022. He was Chairman & CEO of Therapeutics Acquisition Corp. from April 2020. He serves on the boards of life science companies. He served on the Board of Global Science and Technology for the National Academy of Sciences. He has Ph.D. in Virology from Harvard University, B.A. in Biology from Cornell University.
Positions
- Company NameARS Pharmaceuticals, Inc.Stock CodeSPRYPositionIndependent DirectorColleagues
- JCJustin ChakmaChief Business Officer
- PSPratik ShahChairman of the Board
- DCDonn CasaleCEO, President & Director
- RBRobert BellCo-Founder & Chief Science Officer
- KDKathleen D. ScottChief Financial Officer
- BTBrian T. DorseyChief Operating Officer
- PKPeter KolchinskyIndependent Director
- PMPhillip M. SchneiderIndependent Director
- SISaqib IslamIndependent Director
- Company NameFreenome, Inc.Stock CodeFRNMPositionIndependent DirectorColleagues
- AEAaron ElliottCEO & Director
- RERiley EnnisCo-Founder & Chief Product Officer
- LHLinh H. LeChief Financial Officer
- CLCheng-Ho LinChief Scientific Officer
- TFThomas F. FitzpatrickChief Legal Officer
- RWRandal W. ScottIndependent Director
- DPDeepa PakianathanIndependent Director
- DMDouglas M. VanOortIndependent Director
